These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. EXP3174, a metabolite of losartan (MK 954, DuP 753) is more potent than losartan in blocking the angiotensin II-induced responses in vascular smooth muscle cells. Sachinidis A, Ko Y, Weisser P, Meyer zu Brickwedde MK, Düsing R, Christian R, Wieczorek AJ, Vetter H. J Hypertens; 1993 Feb; 11(2):155-62. PubMed ID: 8385175 [Abstract] [Full Text] [Related]
9. Angiotensin II receptors involved in the enhancement of noradrenergic transmission in the caudal artery of the spontaneously hypertensive rat. Cox SL, Story DF, Ziogas J. Br J Pharmacol; 1996 Nov; 119(5):965-75. PubMed ID: 8922747 [Abstract] [Full Text] [Related]
10. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. Levy BI, Benessiano J, Henrion D, Caputo L, Heymes C, Duriez M, Poitevin P, Samuel JL. J Clin Invest; 1996 Jul 15; 98(2):418-25. PubMed ID: 8755652 [Abstract] [Full Text] [Related]
11. HR 720, a novel angiotensin receptor antagonist inhibits the angiotensin II-induced trophic effects, fibronectin release and fibronectin-EIIIA+ expression in rat aortic vascular smooth muscle cells in vitro. Dunn FW, Roux MH, Farhadian F, Sabri K, Ossart C, Samuel JL, Rappaport L, Hamon G. J Pharmacol Exp Ther; 1997 Jan 15; 280(1):447-53. PubMed ID: 8996227 [Abstract] [Full Text] [Related]
12. Angiotensin II- and IV-induced changes in cerebral blood flow. Roles of AT1, AT2, and AT4 receptor subtypes. Kramár EA, Harding JW, Wright JW. Regul Pept; 1997 Jan 29; 68(2):131-8. PubMed ID: 9110385 [Abstract] [Full Text] [Related]
13. Bimodal effects of angiotensin II on migration of human and rat smooth muscle cells. Direct stimulation and indirect inhibition via transforming growth factor-beta 1. Liu G, Espinosa E, Oemar BS, Lüscher TF. Arterioscler Thromb Vasc Biol; 1997 Jul 29; 17(7):1251-7. PubMed ID: 9261254 [Abstract] [Full Text] [Related]
14. The angiotensin type 2 receptor mediates RNA synthesis in A10 vascular smooth muscle cells. Saward L, Zahradka P. J Mol Cell Cardiol; 1996 Mar 29; 28(3):499-506. PubMed ID: 9011633 [Abstract] [Full Text] [Related]
16. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174. Dickinson KE, Cohen RB, Skwish S, Delaney CL, Serafino RP, Poss MA, Gu Z, Ryono DE, Moreland S, Powell JR. Br J Pharmacol; 1994 Sep 29; 113(1):179-89. PubMed ID: 7812609 [Abstract] [Full Text] [Related]
17. Effect of SR 47436, a novel angiotensin II AT1 receptor antagonist, on human vascular smooth muscle cells in vitro. Herbert JM, Delisée C, Dol F, Schaeffer P, Cazaubon C, Nisato D, Chatelain P. Eur J Pharmacol; 1994 Jan 14; 251(2-3):143-50. PubMed ID: 8149971 [Abstract] [Full Text] [Related]
18. Angiotensin II-induced responses in vascular smooth muscle cells: inhibition by non-peptide receptor antagonists. Catalioto RM, Porchia R, Renzetti AR, Criscuoli M, Subissi A, Giachetti A. Eur J Pharmacol; 1995 Jul 14; 280(3):285-92. PubMed ID: 8566096 [Abstract] [Full Text] [Related]